Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Peter Libby MD
Peter Libby MD Advisory Board
Anne Valente MD
Anne Marie Valente MD Advisory Board
See All Experts
story of the week
Published in Cardiology and
2 other channels

Journal Scan / Research · March 06, 2024

Cardiovascular Outcomes Associated With Glucose-Lowering Medications in Patients With Type 2 Diabetes

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Giselle Suero-Abreu MD, PhD, MSc

Deborah Wexler MD, MSc

Circulation
Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)
Circulation 2024 Feb 12;[EPub Ahead of Print], JB Green, BM Everett, A Ghosh, N Younes, H Krause-Steinrauf, J Barzilay, C Desouza, SE Inzucchi, Y Pokharel, D Schade, A Scrymgeour, MH Tan, KM Utzschneider, S Mudaliar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated